Sign up for our newsletter and get Genome updates in your inbox.
By Eric Celeste
Why me? That was the question Jay “Marty” Tenenbaum couldn’t answer, the one that haunted him. He did not ask himself this question in 1998, when …
By John Lugo
A vaccine for Parkinson’s disease has shown promising results in a Phase 1 clinical trial and will soon undergo a follow-up study. The drug, known as …